agilon health (AGL) is proposing a reverse stock split at a ratio between 1-for-5 and 1-for-25 to address its share price falling below the NYSE’s minimum bid requirement of $1.00. The company received a non-compliance notice on November 5, 2025, and believes the split could help it regain compliance and improve marketability to institutional investors. While the board recommends approval, it acknowledges risks such as negative investor perception and no guarantee of sustained price increase or restored liquidity.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Reverse split proposal highlights NYSE bid risk for agilon health (AGL)
agilon health (AGL) is proposing a reverse stock split at a ratio between 1-for-5 and 1-for-25 to address its share price falling below the NYSE’s minimum bid requirement of $1.00. The company received a non-compliance notice on November 5, 2025, and believes the split could help it regain compliance and improve marketability to institutional investors. While the board recommends approval, it acknowledges risks such as negative investor perception and no guarantee of sustained price increase or restored liquidity.